TY - JOUR A1 - Wetzke, Martin A1 - Kopp, Matthias A1 - Seidenberg, Jürgen A1 - Vogelberg, Christian A1 - Ankermann, Tobias A1 - Happle, Christine A1 - Voigt, Gesche A1 - Köster, Holger A1 - Illig, Thomas A1 - Lex, Christiane A1 - Schuster, Antje A1 - Panning, Marcus A1 - Barten, Grit A1 - Rohde, Gernot Gerhard Ulrich A1 - Welte, Tobias A1 - Hansen, Gesine T1 - PedCAPNETZ – prospective observational study on community acquired pneumonia in children and adolescents T2 - BMC pulmonary medicine N2 - Background: Pediatric community acquired pneumonia (pedCAP) is one of the leading causes for childhood morbidity accounting for up to 20% of pediatric hospital admissions in high income countries. In spite of its high morbidity, updated epidemiological and pathogen data after introduction of preventive vaccination and novel pathogen screening strategies are limited. Moreover, there is a need for validated recommendations on diagnostic and treatment regimens in pedCAP. Through collection of patient data and analysis of pathogen and host factors in a large sample of unselected pedCAP patients in Germany, we aim to address and substantially improve this situation. Methods: pedCAPNETZ is an observational, multi-center study on pedCAP. Thus far, nine study centers in hospitals, outpatient clinics and practices have been initiated and more than 400 patients with radiologically confirmed pneumonia have been enrolled, aiming at a total of 1000 study participants. Employing an online data base, information on disease course, treatment as well as demographical and socioeconomical data is recorded. Patients are followed up until day 90 after enrollment; Comprehensive biosample collection and a central pedCAPNETZ biobank allow for in-depth analyses of pathogen and host factors. Standardized workflows to assure sample logistics and data management in more than fifteen future study centers have been established. Discussion: Through comprehensive epidemiological, clinical and biological analyses, pedCAPNETZ fills an important gap in pediatric and infection research. To secure dissemination of the registry, we will raise clinical and scientific awareness at all levels. We aim at participating in decision making processes for guidelines and prevention strategies. Ultimately, we hope the results of the pedCAPNETZ registry will help to improve care and quality of life in pedCAP patients in the future. Y1 - 2019 UR - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/53065 UR - https://nbn-resolving.org/urn:nbn:de:hebis:30:3-530651 SN - 1471-2466 N1 - Open Access: This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. VL - 19 IS - 1, Art. 238 SP - 1 EP - 7 PB - BioMed Central CY - London ER -